ORAGENICS, INC. Disposal Group, Including Discontinued Operation, Deferred Revenue
ORAGENICS, INC. (OGEN) had Disposal Group, Including Discontinued Operation, Deferred Revenue of $0 as of 2016-12-31, per its 10-K filed 2017-02-27.
Discontinued › Balance Sheet › Liabilities › Disposal Group, Including Discontinued Operation, Liabilities
us-gaap:DisposalGroupIncludingDiscontinuedOperationDeferredRevenue · last filed 2017-02-27
- 2016-12-31: Disposal Group, Including Discontinued Operation, Deferred Revenue $0.00.
- 2016-09-30: Disposal Group, Including Discontinued Operation, Deferred Revenue $0.00.
- 2016-06-30: Disposal Group, Including Discontinued Operation, Deferred Revenue $0.00.
- 2015-12-31: Disposal Group, Including Discontinued Operation, Deferred Revenue $14.21K.
| Period end | Disposal Group, Including Discontinued Operation, Deferred Revenue |
|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-02-27 |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-15 |
| 2015-12-31 | $14.21K 10-K · filed 2017-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |